Loading stock data…
AVNS
$25.03+0.03 (+0.12%)
After Hours$25.03+0.00 (+0.00%)· Last close Jun 9
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Avanos Medical, Inc. in the Healthcare sector is trading at $25.03. The stock is currently near its 52-week high of $25.49, remaining 67.9% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$25.03
Potential Downside
0%
Whystock Fair Value$25.03
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-9.51%
Volume
Today's trading volume
633,938
Recent News
Avanos Medical (AVNS) Up 1.1% Since Last Earnings Report: Can It Continue?
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
A Look At Avanos Medical (AVNS) Valuation After Recent 3 Month Share Price Surge
Avanos Medical stock: context for recent performance Avanos Medical (AVNS) has drawn fresh attention after a strong past 3 months, during which the stock returned about 81%. That move comes alongside annual revenue of $715.9 million and a reported net loss of $74.4 million. See our latest analysis for Avanos Medical. That surge sits in contrast to a longer track record where the 1 year total shareholder return is about 100.3%, while the 3 year total shareholder return declined 2.4% and the 5...
New Strong Sell Stocks for May 15th
AVNS, BKR and CAG have been added to the Zacks Rank #5 (Strong Sell) List on May 15th, 2026.
Deciphering Avanos Medical (AVNS) International Revenue Trends
Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
AVNS Gains After Posting Q1 Earnings Miss & Revenue Beat, Margins Down
Avanos Medical tops Q1 revenue estimates on strong SNS growth, but margin pressure and PM&R weakness weigh on earnings and profitability.